← Back to Analyst Consensus 
PROK Buy
PROKIDNEY CORP.
Current Price —
Implied Upside —
Analysts 14
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 9, 2026 (13 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| May 18, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Dec 16, 2025 | HC Wainwright & Co. | initiate | — → Buy | $12 | 44% |
| Jul 15, 2025 | UBS | maintain | Buy → Buy | $8 | 54% |
| Jul 14, 2025 | Guggenheim | maintain | Buy → Buy | $7 | 52% |
| Jul 9, 2025 | Citigroup | maintain | Buy → Buy | $9 | 54% |
| Jun 30, 2025 | B of A Securities | downgrade | Neutral → Underperform | $1 | 53% |
| Sep 30, 2024 | JP Morgan | initiate | — → Neutral | $0 | 54% |
| Sep 10, 2024 | Guggenheim | initiate | — → Buy | $6 | 52% |
| Sep 4, 2024 | B of A Securities | maintain | Neutral → Neutral | $3 | 53% |
| Jun 10, 2024 | Jefferies | maintain | Buy → Buy | $6 | 52% |
| May 29, 2024 | B of A Securities | maintain | Neutral → Neutral | $4 | 53% |
| Jan 2, 2024 | B of A Securities | downgrade | Buy → Neutral | $2 | 53% |
| Jul 25, 2023 | BTIG | initiate | — → Buy | $16 | 52% |
| Dec 21, 2022 | Jefferies | initiate | — → Buy | $15 | 52% |
| Nov 10, 2022 | Morgan Stanley | initiate | — → Equal-Weight | $13 | 54% |
| Oct 18, 2022 | UBS | initiate | — → Buy | $18 | 54% |
| Oct 14, 2022 | Citigroup | initiate | — → Buy | $16 | 54% |
| Sep 2, 2022 | Evercore ISI Group | initiate | — → Outperform | $0 | 58% |
Price Target Trend
Apr 26, 2026 Oct 27, 2026
EPS Estimates
+1q —
+1y —
0y —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days